STAT3 and neoplasm: The STAT3 axis was then more specifically targeted with an intravenous injection of a STAT3–small interfering RNA (siRNA)–CpG conjugate which was shown to silence the immune suppressor gene STAT3, reprogramming the functions of TAMs correlated with an immune-mediated tumor rejection [63].